Rebecca Bechhold

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

Denise A. Yardley, Robert Weaver, Michelle Melisko et al. · Journal of Clinical Oncology · 2015 · 189 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score

Denise A. Yardley, N. W. Peacock, Mythili Shastry et al. · Breast Cancer Research and Treatment · 2015 · 56 citations

Medicine, Oncology, Pharmacology +17

Abstract P6-10-01: A randomized phase 2 study of the antibody-drug conjugate CDX-011 in advanced GPNMB-overexpressing breast cancer: The EMERGE study

DA Yardley, R Weaver, ME Melisko et al. · Cancer Research · 2012 · 17 citations

Medicine, Oncology, Pharmacology +17